Journals / Annals of Medical Research / 2020 / Cilt: 27 - Sayı: 9

Serum TWEAK levels in patients with obstructive sleep apnea syndrome

Pages
2484–2488
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

When the correlation between TWEAK levels and sleep-related variables are examined, inversely correlation between TWEAK levels and apnea-hypopnea index, the percentage of total sleep time spent with oxygen saturation below 90% and oxygen desaturation index was found.Conclusion: Serum TWEAK levels in OSAS patients and its relation with sleep variables showed for the first time that TWEAK may be a new inflammatory biomarker for OSAS.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The purpose of the study is to research the serum TWEAK levels in obstructive sleep apnea syndrome (OSAS) patients.Material and Methods: Eighty-six subjects were admitted in the study, 59 being in the patient group and 27 in the control group.
📊
Key Findings & Data:The patient group was further divided into subgroups of severe OSAS and mild-moderate OSAS.
💡
Conclusion & Impact:When the correlation between TWEAK levels and sleep-related variables are examined, inversely correlation between TWEAK levels and apnea-hypopnea index, the percentage of total sleep time spent with oxygen saturation below 90% and oxygen desaturation index was found.Conclusion: Serum TWEAK levels in OSAS patients and its relation with sleep variables showed for the first time that TWEAK may be a new inflammatory biomarker for OSAS.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: The purpose of the study is to research the serum TWEAK levels in obstructive sleep apnea syndrome (OSAS) patients.Material and Methods: Eighty-six subjects were admitted in the study, 59 being in the patient group and 27 in the control group. The patient group was further divided into subgroups of severe OSAS and mild-moderate OSAS. TWEAK levels between the groups were statistically compared. In addition, the correlation of sleep-related variables with TWEAK levels was investigated in the patientgroup.Results: TWEAK levels were lower in the patient group than in the control group. When the correlation between TWEAK levels and sleep-related variables are examined, inversely correlation between TWEAK levels and apnea-hypopnea index, the percentage of total sleep time spent with oxygen saturation below 90% and oxygen desaturation index was found.Conclusion: Serum TWEAK levels in OSAS patients and its relation with sleep variables showed for the first time that TWEAK may be a new inflammatory biomarker for OSAS.

🔖

Cite This Article

KARAKURT, S. E., DERE, H. H., KUM, N., ÇETİN, M. A., TURHAN, T., TOPCUOĞLU, C. (2022). Serum TWEAK levels in patients with obstructive sleep apnea syndrome. Annals of Medical Research, Cilt: 27 - Sayı: 9, 2484–2488. https://ajindex.com/articles/446272

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. The Report of an American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: Recommendations for syndrome definition and measurement techniques in clinical research. Sleep 1999;22:667-89
  2. Atan D, Ozcan KM, Ikinciogulları A, et al. The effect of obstructive sleep apnea syndrome and continuous positive airway pressure treatment on voice performance. Sleep Breath 2015;19:777-82
  3. Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc 2008;5:136-43
  4. Li W, Yu Z, Jiang C. Association of serum YKL-40 with the presence and severity of obstructive sleep apnea syndrome. Lab Med 2014;45:220-5. 5. de Lima FF, Mazzotti DR, Tufik S, et al. The role inflammatory response genes in obstructive sleep apnea syndrome: a review. Sleep Breath 2016;20:331-8
  5. Sato S, Ogura Y, Tajrishi MM, et al. Elevated levels of TWEAK in skeletal muscle promote visceral obesity, insulin resistance, and metabolic dysfunction. FASEB J 2015;29:988-1002
  6. Xu WD, Zhao Y, Liu Y. Role of the TWEAK/Fn14 pathway in autoimmune diseases. Immunol Res 2016;64:44- 50
  7. Martínez-Miguel P, Medrano-Andrés D, Griera-Merino M, et al. Tweak up-regulates endothelin-1 system in mouse and human endothelial cells. Cardiovasc Res 2017;113:207-21
  8. Chang WA, Yen MC, Hung JY, et al. Investigation of the role of tumor necrosis factor-like weak inducer of apoptosis in non-small cell lung cancer. Oncol Rep 2018;39:573-81
  9. Bilgic O, Sivrikaya A, Toker A, et al. Serum levels of TWEAK in patients with psoriasis vulgaris. Cytokine 2016;77:10-3
  10. Jordan W, Cohrs S, Degner D, et al. Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome. J Neural Transm 2006;113:239-54
  11. Vassilakopoulos T, Katsaounou P, Karatza MH, et al. Strenuous resistive breathing induces plasma cytokines: role of antioxidants and monocytes. Am J Respir Crit Care Med 2002;166:1572-8
  12. Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea subjects. Am J Respir Crit Care Med 2002;165:934-9
  13. Inancli HM, Enoz M. Obstructive sleep apnea syndrome and upper airway inflammation. Recent Pat Inflamm Allergy Drug Discov 2010;4:54-7
  14. Wang X, Xing GH. Serum YKL-40 concentrations are elevated and correlated with disease severity in patients with obstructive sleep apnea syndrome. Scand J Clin Lab Invest 2014;74:74-8. 16.Dohi T, Burkly LC. The TWEAK/Fn14 pathway a